{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T07:48:49Z","timestamp":1785743329027,"version":"3.56.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,12,16]],"date-time":"2020-12-16T00:00:00Z","timestamp":1608076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,12,16]],"date-time":"2020-12-16T00:00:00Z","timestamp":1608076800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care North West Coast (NIHR CLAHRC NWC)."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1038\/s41431-020-00783-9","type":"journal-article","created":{"date-parts":[[2020,12,16]],"date-time":"2020-12-16T14:05:41Z","timestamp":1608127541000},"page":"699-708","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Examining the uptake of predictive BRCA testing in the UK; findings and implications"],"prefix":"10.1038","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4383-6038","authenticated-orcid":false,"given":"Antony P.","family":"Martin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Downing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3023-8189","authenticated-orcid":false,"given":"Brendan","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Godman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Alfirevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen Lynn","family":"Greenhalgh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7534-7266","authenticated-orcid":false,"given":"Munir","family":"Pirmohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,12,16]]},"reference":[{"key":"783_CR1","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.ygyno.2012.12.016","volume":"129","author":"G Chornokur","year":"2013","unstructured":"Chornokur G, Amankwah EK, Schildkraut JM, Phelan CM. Global ovarian cancer health disparities. Gynecol Oncol. 2013;129:258\u201364. https:\/\/doi.org\/10.1016\/j.ygyno.2012.12.016.","journal-title":"Gynecol Oncol"},{"key":"783_CR2","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.jacr.2016.10.003","volume":"14","author":"ET Rosenthal","year":"2017","unstructured":"Rosenthal ET, Evans B, Kidd J, Brown K, Gorringe H, van Orman M, et al. Increased identification of candidates for high-risk breast cancer screening through expanded genetic testing. J Am Coll Radiol. 2017;14:561\u20138. https:\/\/doi.org\/10.1016\/j.jacr.2016.10.003.","journal-title":"J Am Coll Radiol"},{"key":"783_CR3","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1200\/JCO.2012.43.1882","volume":"31","author":"E Castro","year":"2013","unstructured":"Castro E, Goh C, Olmos D, Saunders E, Leongamornlert D, Tymrakiewicz M, et al. Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer. J Clin Oncol. 2013;31:1748\u201357. https:\/\/doi.org\/10.1200\/JCO.2012.43.1882.","journal-title":"J Clin Oncol"},{"key":"783_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13053-015-0038-x","volume":"13","author":"H Cavanagh","year":"2015","unstructured":"Cavanagh H, Rogers KMA. The role of BRCA1 and BRCA2 mutations in prostate, pancreatic and stomach cancers. Hered Cancer Clin Pract. 2015;13:1\u20137. https:\/\/doi.org\/10.1186\/s13053-015-0038-x.","journal-title":"Hered Cancer Clin Pract"},{"key":"783_CR5","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1038\/ejhg.2016.93","volume":"24","author":"D Stoppa-Lyonnet","year":"2016","unstructured":"Stoppa-Lyonnet D. The biological effects and clinical implications of BRCA mutations: Where do we go from here?. Eur J Hum Genet. 2016;24:S3\u20139. https:\/\/doi.org\/10.1038\/ejhg.2016.93.","journal-title":"Eur J Hum Genet"},{"key":"783_CR6","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1056\/NEJMra1503523","volume":"374","author":"LC Hartmann","year":"2016","unstructured":"Hartmann LC, Lindor NM. The role of risk-reducing surgery in hereditary breast and ovarian cancer. N Engl J Med. 2016;374:454\u201368. https:\/\/doi.org\/10.1056\/NEJMra1503523.","journal-title":"N Engl J Med"},{"key":"783_CR7","doi-asserted-by":"publisher","first-page":"v103","DOI":"10.1093\/annonc\/mdw327","volume":"27","author":"S Paluch-Shimon","year":"2016","unstructured":"Paluch-Shimon S, Cardoso F, Sessa C, Balmana J, Cardoso MJ, Gilbert F, et al. Prevention and screening in BRCA mutation carriers and other breast\/ovarian hereditary cancer syndromes: ESMO clinical practice guidelines for cancer prevention and screening. Ann Oncol. 2016;27:v103\u201310. https:\/\/doi.org\/10.1093\/annonc\/mdw327.","journal-title":"Ann Oncol"},{"key":"783_CR8","unstructured":"National Breast Cancer Foundation Inc. Genetic testing for breast cancer. https:\/\/www.nationalbreastcancer.org\/genetic-testing-for-breast-cancer. [Accessed 10\/12\/2020]."},{"key":"783_CR9","doi-asserted-by":"publisher","first-page":"3092","DOI":"10.1200\/JCO.2015.60.8596","volume":"33","author":"MB Yurgelun","year":"2015","unstructured":"Yurgelun MB, Hiller E, Garber JE. Population-wide screening for germline BRCA1 and BRCA2 mutations: Too much of a good thing?. J Clin Oncol. 2015;33:3092\u20135. https:\/\/doi.org\/10.1200\/JCO.2015.60.8596.","journal-title":"J Clin Oncol"},{"key":"783_CR10","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s10689","volume":"41","author":"SM Mahon","year":"2014","unstructured":"Mahon SM. Cancer risks for men with BRCA1\/2 mutations. Oncol Nurs Forum. 2014;41:99\u2013101. https:\/\/doi.org\/10.1007\/s10689.","journal-title":"Oncol Nurs Forum"},{"key":"783_CR11","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.pec.2017.07.015","volume":"101","author":"EA Rauscher","year":"2018","unstructured":"Rauscher EA, Dean M. \u201cI\u2019ve just never gotten around to doing it\u201d: men\u2019s approaches to managing BRCA-related cancer risks. Patient Educ Couns. 2018;101:340\u20135.","journal-title":"Patient Educ Couns"},{"key":"783_CR12","unstructured":"NICE. Familial breast cancer: the classification and care of people at risk of familial breast cancer and management of breast cancer and related risks in people with a family history of breast cancer. Clinical Guideline 164. London; 2013. http:\/\/guidance.nice.org.uk\/CG164."},{"key":"783_CR13","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1136\/bmj.322.7293.1052","volume":"322","author":"JP Evans","year":"2001","unstructured":"Evans JP, Skrzynia C, Burke W. The complexities of predictive genetic testing. BMJ. 2001;322:1052\u20136. https:\/\/doi.org\/10.1136\/bmj.322.7293.1052.","journal-title":"BMJ."},{"key":"783_CR14","doi-asserted-by":"publisher","first-page":"14205","DOI":"10.1073\/pnas.1415979111","volume":"111","author":"E Gabai-Kapara","year":"2014","unstructured":"Gabai-Kapara E, Lahad A, Kaufman B, Friedman E, Segev S, Renbaum P, et al. Population-based screening for breast and ovarian cancer risk due to BRCA1 and BRCA2. Proc Natl Acad Sci USA. 2014;111:14205\u201310. https:\/\/doi.org\/10.1073\/pnas.1415979111.","journal-title":"Proc Natl Acad Sci USA"},{"key":"783_CR15","doi-asserted-by":"publisher","unstructured":"Sayani A. Inequities in genetic testing for hereditary breast cancer: implications for public health practice. J Community Genet. 2018;1\u20135. https:\/\/doi.org\/10.1007\/s12687-018-0370-8.","DOI":"10.1007\/s12687-018-0370-8"},{"key":"783_CR16","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s10689-008-9184-x","volume":"7","author":"SM Holloway","year":"2008","unstructured":"Holloway SM, Bernhard B, Campbell H, Cetnarskyj R, Lam WWK. Inequality of use of cancer genetics services by members of breast, ovarian and colorectal cancer families in South East Scotland. Fam Cancer. 2008;7:259\u201364. https:\/\/doi.org\/10.1007\/s10689-008-9184-x.","journal-title":"Fam Cancer"},{"key":"783_CR17","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s10549-015-3374-7","volume":"151","author":"D Cragun","year":"2015","unstructured":"Cragun D, Bonner D, Kim J, Akbari MR, Narod SA, Gomez-Fuego A, et al. Factors associated with genetic counseling and BRCA testing in a population-based sample of young Black women with breast cancer. Breast Cancer Res Treat. 2015;151:169\u201376. https:\/\/doi.org\/10.1007\/s10549-015-3374-7.","journal-title":"Breast Cancer Res Treat"},{"key":"783_CR18","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/cncr.28966","volume":"121","author":"RA Yusuf","year":"2015","unstructured":"Yusuf RA, Rogith D, Hovick SRA, Peterson SK, Burton-Chase AM, Fellman BM, et al. Attitudes toward molecular testing for personalized cancer therapy. Cancer. 2015;121:243\u201350. https:\/\/doi.org\/10.1002\/cncr.28966.","journal-title":"Cancer."},{"key":"783_CR19","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.amepre.2014.01.002","volume":"46","author":"PL Mai","year":"2014","unstructured":"Mai PL, Vadaparampil ST, Breen N, McNeel TS, Wideroff L, Graubard BI. Awareness of cancer susceptibility genetic testing: the 2000, 2005, and 2010 national health interview surveys. Am J Prev Med. 2014;46:440\u20138. https:\/\/doi.org\/10.1016\/j.amepre.2014.01.002.","journal-title":"Am J Prev Med"},{"key":"783_CR20","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1155\/2012\/309109","volume":"2012","author":"LJ Finney Rutten","year":"2012","unstructured":"Finney Rutten LJ, Gollust SE, Naveed S, Moser RP. Increasing public awareness of direct-to-consumer genetic tests: Health care access, internet use, and population density correlates. J Cancer Epidemiol. 2012;2012:6\u201310. https:\/\/doi.org\/10.1155\/2012\/309109.","journal-title":"J Cancer Epidemiol"},{"key":"783_CR21","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1159\/000111638","volume":"11","author":"JE Heck","year":"2008","unstructured":"Heck JE, Franco R, Jurkowski JM, Sheinfeld Gorin S. Awareness of genetic testing for cancer among United States hispanics: the role of acculturation. Community Genet. 2008;11:36\u201342. https:\/\/doi.org\/10.1159\/000111638.","journal-title":"Community Genet"},{"key":"783_CR22","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/gim.2014.125","volume":"17","author":"M Butrick","year":"2015","unstructured":"Butrick M, Kelly S, Peshkin BN, Luta G, Nusbaum R, Hooker GW, et al. Uptake of BRCA1\/2 genetic testing in a randomized trial of telephone counseling. Genet Med. 2015;17:467\u201375. https:\/\/doi.org\/10.1038\/gim.2014.125.","journal-title":"Genet Med"},{"key":"783_CR23","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.amepre.2009.07.021","volume":"37","author":"J Pagan","year":"2009","unstructured":"Pagan J, Su D, Li L, Armstrong K, Asch DA. Racial and ethnic disparities in awareness of genetic testing for cancer risk. Am J Prev Med. 2009;37:524\u201330. https:\/\/doi.org\/10.1016\/j.amepre.2009.07.021.","journal-title":"Am J Prev Med"},{"key":"783_CR24","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1159\/000164684","volume":"12","author":"C Molster","year":"2009","unstructured":"Molster C, Charles T, Samanek A, O\u2019Leary P. Australian study on public knowledge of human genetics and health. Public Health Genom. 2009;12:84\u201391. https:\/\/doi.org\/10.1159\/000164684.","journal-title":"Public Health Genom"},{"key":"783_CR25","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1530\/ERC-14-0411","volume":"12","author":"SB Haga","year":"2012","unstructured":"Haga SB, O\u2019Daniel JM, Tindall GM, Lipkus IR, Agans R. Survey of U.S. public attitudes towards pharmacogenetic testing. Pharmacogenomics J. 2012;12:197\u2013204. https:\/\/doi.org\/10.1530\/ERC-14-0411.","journal-title":"Pharmacogenomics J"},{"key":"783_CR26","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1093\/heapro\/6.3.217","volume":"6","author":"M Whitehead","year":"1991","unstructured":"Whitehead M. The concepts and principles of equity and health. Health Promot Int. 1991;6:217\u201328. https:\/\/doi.org\/10.1093\/heapro\/6.3.217.","journal-title":"Health Promot Int"},{"key":"783_CR27","unstructured":"Department for Communities and Local Government. The english index of multiple deprivation (IMD) 2015\u2014guidance. 2015. https:\/\/www.gov.uk\/government\/statistics\/english-indices-ofdeprivation-2015. Accessed 2 May 2020."},{"key":"783_CR28","doi-asserted-by":"crossref","unstructured":"Klein J, Moeschberger M. Survival analysis: techniques for censored and truncated data. 2nd ed. New York: Springer; 2003.","DOI":"10.1007\/b97377"},{"key":"783_CR29","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1002\/sim.4780141510","volume":"14","author":"KR Hess","year":"1995","unstructured":"Hess KR. Graphical methods for assessing violations of the proportional hazards assumption in cox regression. Stat Med. 1995;14:1707\u201323. https:\/\/doi.org\/10.1002\/sim.4780141510.","journal-title":"Stat Med"},{"key":"783_CR30","doi-asserted-by":"publisher","first-page":"b2393.","DOI":"10.1136\/bmj.b2393","volume":"338","author":"JAC Sterne","year":"2009","unstructured":"Sterne JAC, White IR, Carlin JB, Spratt M, Royston P, Kenward MG, et al. Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ. 2009;338:b2393. https:\/\/doi.org\/10.1136\/bmj.b2393.","journal-title":"BMJ."},{"key":"783_CR31","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1038\/gim.2016.29","volume":"18","author":"E D\u2019Andrea","year":"2016","unstructured":"D\u2019Andrea E, Marzuillo C, De Vito C, Di Marco M, Pitini E, Vacchio MR, et al. Which BRCA genetic testing programs are ready for implementation in health care? A systematic review of economic evaluations. Genet Med. 2016;18:1171\u201380. https:\/\/doi.org\/10.1038\/gim.2016.29.","journal-title":"Genet Med"},{"key":"783_CR32","doi-asserted-by":"publisher","first-page":"329.e1","DOI":"10.1016\/j.ajog.2013.01.026","volume":"208","author":"K Singh","year":"2013","unstructured":"Singh K, Lester J, Karlan B, Bresee C, Geva T, Gordon O. Impact of family history on choosing risk-reducing surgery among BRCA mutation carriers. Am J Obstet Gynecol. 2013;208:329.e1\u20136. https:\/\/doi.org\/10.1016\/j.ajog.2013.01.026.","journal-title":"Am J Obstet Gynecol"},{"key":"783_CR33","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41416-019-0446-1","volume":"121","author":"K Metcalfe","year":"2019","unstructured":"Metcalfe K, Eisen A, Senter L, Risch HA, Rosen B, Murphy J, et al. International trends in the uptake of cancer risk reduction strategies in women with a BRCA1 or BRCA2 mutation. Br J Cancer. 2019;121:15\u201321. https:\/\/doi.org\/10.1038\/s41416-019-0446-1.","journal-title":"Br J Cancer"},{"key":"783_CR34","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/ejhg.2013.143","volume":"22","author":"R MacLeod","year":"2013","unstructured":"MacLeod R, Beach A, Henriques S, Knopp J, Nelson K, Kerzin-Storrar L. Experiences of predictive testing in young people at risk of Huntington\u2019s disease, familial cardiomyopathy or hereditary breast and ovarian cancer. Eur J Hum Genet. 2013;22:396. https:\/\/doi.org\/10.1038\/ejhg.2013.143.","journal-title":"Eur J Hum Genet"},{"key":"783_CR35","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s10897-015-9845-5","volume":"25","author":"K Brunstrom","year":"2016","unstructured":"Brunstrom K, Murray A, McAllister M. Experiences of women who underwent predictive BRCA 1\/2 mutation testing before the age of 30. J Genet Couns. 2016;25:90\u2013100. https:\/\/doi.org\/10.1007\/s10897-015-9845-5.","journal-title":"J Genet Couns"},{"key":"783_CR36","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1038\/gim.2017.52","volume":"19","author":"E Healey","year":"2017","unstructured":"Healey E, Taylor N, Greening S, Wakefield CE, Warwick L, Williams R, et al. Quantifying family dissemination and identifying barriers to communication of risk information in Australian BRCA families. Genet Med. 2017;19:1323\u201331. https:\/\/doi.org\/10.1038\/gim.2017.52.","journal-title":"Genet Med"},{"key":"783_CR37","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10897-013-9592-4","volume":"22","author":"J Fehniger","year":"2013","unstructured":"Fehniger J, Lin F, Beattie MS, Joseph G, Kaplan C. Family communication of BRCA1\/2 results and family uptake of BRCA1\/2 testing in a diverse population of BRCA1\/2 carriers. J Genet Couns. 2013;22:603\u201312. https:\/\/doi.org\/10.1007\/s10897-013-9592-4.","journal-title":"J Genet Couns"},{"key":"783_CR38","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1158\/1055-9965.EPI-10-0325","volume":"19","author":"EL Cheung","year":"2010","unstructured":"Cheung EL, Olson AD, Yu TM, Han PZ, Beattie MS. Communication of BRCA results and family testing in 1,103 high-risk women. Cancer Epidemiol Biomark Prev. 2010;19:2211\u20139. https:\/\/doi.org\/10.1158\/1055-9965.EPI-10-0325.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"783_CR39","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1038\/gim.2018.26","volume":"20","author":"S Lieberman","year":"2018","unstructured":"Lieberman S, Lahad A, Tomer A, Koka S, BenUziyahu M, Raz A, et al. Familial communication and cascade testing among relatives of BRCA population screening participants. Genet Med. 2018;20:1446\u201354. https:\/\/doi.org\/10.1038\/gim.2018.26.","journal-title":"Genet Med"},{"key":"783_CR40","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s10689-018-0089-z","volume":"18","author":"FH Menko","year":"2019","unstructured":"Menko FH, ter Stege JA, van der Kolk LE, Jeanson KN, Schats W, Moha DA, et al. The uptake of presymptomatic genetic testing in hereditary breast-ovarian cancer and Lynch syndrome: a systematic review of the literature and implications for clinical practice. Fam Cancer. 2019;18:127\u201335. https:\/\/doi.org\/10.1007\/s10689-018-0089-z.","journal-title":"Fam Cancer"},{"key":"783_CR41","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s10689-015-9854-4","volume":"15","author":"E Sermijn","year":"2016","unstructured":"Sermijn E, Delesie L, Deschepper E, Pauwels I, Bonduelle M, Teugels E, et al. The impact of an interventional counselling procedure in families with a BRCA1\/2 gene mutation: efficacy and safety. Fam Cancer. 2016;15:155\u201362. https:\/\/doi.org\/10.1007\/s10689-015-9854-4.","journal-title":"Fam Cancer"},{"key":"783_CR42","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s12687-012-0132-y","volume":"4","author":"L Black","year":"2013","unstructured":"Black L, McClellan KA, Avard D, Knoppers BM. Intrafamilial disclosure of risk for hereditary breast and ovarian cancer: points to consider. J Community Genet. 2013;4:203\u201314. https:\/\/doi.org\/10.1007\/s12687-012-0132-y.","journal-title":"J Community Genet"},{"key":"783_CR43","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1007\/s10897-014-9805-5","volume":"24","author":"R George","year":"2015","unstructured":"George R, Kovak K, Cox SL. Aligning policy to promote cascade genetic screening for prevention and early diagnosis of heritable diseases. J Genet Couns. 2015;24:388\u201399. https:\/\/doi.org\/10.1007\/s10897-014-9805-5.","journal-title":"J Genet Couns"},{"key":"783_CR44","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1177\/0968533217721966","volume":"17","author":"C Mitchell","year":"2017","unstructured":"Mitchell C, Goodwin D, Ploem C, Bell J, Hennekam R, Wallace S, et al. Exploring the potential duty of care in clinical genomics under UK law. Med Law Int. 2017;17:158\u201382. https:\/\/doi.org\/10.1177\/0968533217721966.","journal-title":"Med Law Int"},{"key":"783_CR45","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/gim.2017.257","volume":"20","author":"MA Rothstein","year":"2018","unstructured":"Rothstein MA. Reconsidering the duty to warn genetically at-risk relatives. Genet Med. 2018;20:285\u201390. https:\/\/doi.org\/10.1038\/gim.2017.257.","journal-title":"Genet Med"},{"key":"783_CR46","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s10897-017-0164-x","volume":"27","author":"S Dheensa","year":"2018","unstructured":"Dheensa S, Lucassen A, Fenwick A. Limitations and pitfalls of using family letters to communicate genetic risk: a qualitative study with patients and healthcare professionals. J Genet Couns. 2018;27:689\u2013701. https:\/\/doi.org\/10.1007\/s10897-017-0164-x.","journal-title":"J Genet Couns"},{"key":"783_CR47","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1001\/jama.2014.17442","volume":"313","author":"M-C King","year":"2015","unstructured":"King M-C, Lahad A, Levy-Lahad E. Proposed shift in screening for breast cancer-reply. JAMA. 2015;313:525\u20136. https:\/\/doi.org\/10.1001\/jama.2014.17442.","journal-title":"JAMA."},{"key":"783_CR48","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1001\/jama.2014.12483","volume":"312","author":"M-C King","year":"2014","unstructured":"King M-C, Levy-Lahad E, Lahad A. Population-based screening for BRCA1 and BRCA2: 2014 Lasker Award. JAMA. 2014;312:1091\u20132. https:\/\/doi.org\/10.1001\/jama.2014.12483.","journal-title":"JAMA."}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41431-020-00783-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41431-020-00783-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41431-020-00783-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:01:17Z","timestamp":1684616477000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41431-020-00783-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,16]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["783"],"URL":"https:\/\/doi.org\/10.1038\/s41431-020-00783-9","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,16]]},"assertion":[{"value":"4 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"HRA REC 227795\/17CAG0183 approved.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}